Sopartec
Overview
Sopartec is the technology transfer and investment company for the Université catholique de Louvain (UCLouvain), focused on creating spin-offs from university research and investing in them.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| 3D-Side | - | Seed | Co-investor |
| Sunrise Group | Sep 2025 | VC Round | Co-investor |
| Aphea.Bio | Nov 2020 | Series B | Co-investor |
| ExeVir Bio | Mar 2021 | Series A | Co-investor |
| Promethera Biosciences | Jun 2021 | Corporate Funding | Co-investor |
For institutional investors. Book with your work email.
Key People
François Blondel
Director
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Sopartec based?
Sopartec is headquartered in Louvain-la-Neuve, Belgium.
When was Sopartec founded?
Sopartec was founded in 1992.
How many portfolio companies does Sopartec have?
Sopartec has 8 portfolio companies in Caplight's dataset.
What are some companies in Sopartec's portfolio?
Portfolio companies visible on Caplight include 3D-Side, Sunrise Group, Aphea.Bio, ExeVir Bio, Promethera Biosciences.
What was Sopartec's most recent investment shown here?
Sopartec's most recent investment in this portfolio sample was in Sunrise Group in 2025.
What sectors does Sopartec focus on?
Sopartec focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Healthcare & Life Sciences, Energy & Sustainability, Enterprise Software, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Sopartec focus on?
Sopartec typically invests at the Early stage.